Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous ESP Blocks for Postoperative Pain in Gynecologic Surgery
NCT05082155Phase 4Withdrawn
- Sponsor
- University of California, San Diego
- Start
- Jan 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by University of California, San Diego. Planned start Jan 2022; status: withdrawn.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05082155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05082155.